List of insiders holdings for Forte Biosciences Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
GRUBER HARRY E President, Science&Innovation | 2020-02-28 16:32:16 | 23,685 417,753 | 441,438 | Form 4 |
Chen Hubert C See remarks | 2024-01-03 16:04:40 | 183,405 0 | 183,405 | Form 4 |
Wagner Paul A. SEE REMARKS | 2024-10-02 18:19:04 | 88,720 0 | 88,720 | Form 4 |
Das Asha SVP & Chief Medical Officer | 2018-03-02 17:13:25 | 70,000 0 | 70,000 | Form 4 |
Eichenfield Lawrence Director | 2024-08-22 16:12:00 | 50,000 0 | 50,000 | Form 4 |
GRYSKA DAVID W Director | 2024-08-22 16:11:04 | 50,000 0 | 50,000 | Form 4 |
Kornfeld Steven Director | 2024-08-22 16:10:19 | 50,000 0 | 50,000 | Form 4 |
Doberstein Stephen K Director | 2024-08-22 16:09:23 | 50,000 0 | 50,000 | Form 4 |
Duvall Martin J Chief Executive Officer | 2019-10-04 20:34:10 | 50,000 0 | 50,000 | Form 4 |
FINCK BARBARA K Director | 2024-08-22 16:08:36 | 50,000 0 | 50,000 | Form 4 |
Williams Donald Allen Director | 2024-08-22 16:07:40 | 50,000 0 | 50,000 | Form 4 |
Brun Scott C. Director | 2024-08-22 16:06:39 | 50,000 0 | 50,000 | Form 4 |
Riley Antony A CHIEF FINANCIAL OFFICER | 2024-11-22 17:45:42 | 30,776 0 | 30,776 | Form 4 |
FOLETTA MARK G EVP & Chief Financial Officer | 2019-10-04 20:38:01 | 30,000 0 | 30,000 | Form 4 |
DARCY THOMAS E Director | 2021-01-14 19:17:31 | 2,358 24,637 | 26,995 | Form 4 |
Walker Patricia S Director | 2022-06-02 17:13:27 | 25,000 0 | 25,000 | Form 4 |
Kabbinavar Fairooz SVP Clinical Development | 2019-10-04 20:36:06 | 20,000 0 | 20,000 | Form 4 |
Jolly Douglas EVP, Research & Pharm Devel | 2019-10-04 20:40:19 | 12,500 0 | 12,500 | Form 4 |
Kunkel Lori Anne Director | 2019-10-04 20:31:31 | 7,500 0 | 7,500 | Form 4 |
BERGER FRANKLIN M Director | 2019-10-04 20:29:49 | 7,500 0 | 7,500 | Form 4 |
Hasnain Faheem Director | 2019-10-04 20:22:03 | 7,500 0 | 7,500 | Form 4 |
Parkinson David Ross Director | 2019-10-04 20:14:03 | 7,500 0 | 7,500 | Form 4 |
SCHIMMEL PAUL Director | 2019-10-04 20:11:39 | 7,500 0 | 7,500 | Form 4 |
VINCENT RICHARD G Director | 2024-09-19 18:30:10 | 2,000 0 | 2,000 | Form 4 |
Kapoor Shivpreet Singh Director | 2024-09-19 18:31:10 | 2,000 0 | 2,000 | Form 4 |
Oliveira Steven Michael 10% Owner | 2021-09-21 13:31:44 | 0 0 | 0 | Form 13G |
BERMAN DENNIS N former director & officer Director | 2017-04-17 18:23:38 | 0 0 | 0 | Form 4 |